We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
INTEGRA BIOSCIENCES AG

Download Mobile App





Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2018
Fujifilm Corporation (Tokyo, Japan) showcased its new generation dry chemistry analyzer series, DRI-CHEM NX700, which can perform multiple test parameters of clinical chemistry, at MEDLAB Middle East 2018.
 
Fujifilm is a pioneer in diagnostic imaging and information systems for healthcare facilities and also provides Point-of-Care Testing products for healthcare providers who need immediate clinical test results. More...
At MEDLAB Middle East 2018, the world’s largest attended laboratory & IVD exhibition and conference held in Dubai, UAE from February 5-8, 2018, Fujifilm showcased its DRI-CHEM NX700 dry chemistry analyzer series which offers a high processing speed of 190 tests per hour and makes it possible to set five samples at the same time.
 
Equipped with STAT functionality to accommodate emergency interrupt measurement, the DRI-CHEM NX700 does not require pre-treatment of sample or calibration using the QC card system. It offers easy operations with a touch screen and intuitive new software, along with enhanced connectivity features and HL7 support. The DRI-CHEM NX700 dry chemistry analyzer series is patient-friendly as it requires a testing microsample of only 6 μL and 10 μL per test. Featuring a new design with a compact size and smaller foot print, it allows for the use of different range of sample tubes.
 

Visit expo >
Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Latest MEDLAB 2018 News

Channels

Clinical Chemistry

view channel
Blood Test Tracks Transplant Health Using Donor DNA
AI Sensor Detects Neurological Disorders Using Single Saliva Drop
New Blood Test Index Offers Earlier Detection of Liver Scarring
Image: The AI-assisted spectroscopy technique rapidly differentiates myocardial infarction from aortic dissection (Photo courtesy of Adobe Stock)

AI-Powered Blood Test Distinguishes Deadly Cardiac Events

Two life-threatening cardiovascular emergencies—myocardial infarction and aortic dissection—often present with the same symptom: sudden, severe chest pain. Yet the treatments for these conditions are fundamentally... Read more

Molecular Diagnostics

view channel
New Blood Test Aims to Transform Liver Cancer Surveillance
Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug
Clinical Diagnostic Test Detects Additional Genetic Variants in Acute Leukemia P...
Image: The CardiOmicScore model was built using deep learning methods that integrate large-scale multiomics datasets, including genomics, proteomics, and metabolomics (Luo, Y., Zhang, N., Yang, J. et al. Nat Commun (2026); doi.org/10.1038/s41467-026-68956-6)

Single Blood Test Predicts Heart Diseases 15 Years Before Onset

Cardiovascular diseases remain the leading cause of death worldwide, claiming nearly 19.8 million lives in 2022 alone. Early identification of individuals at risk is critical for prevention, yet conventional... Read more

Hematology

view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Fast and Easy Test Could Revolutionize Blood Transfusions
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Image: Hemex Health’s Gazelle platform is designed to rapidly separate and detect hemoglobin fractions and variants using miniaturized electrophoresis technology (photo courtesy of Hemex Health)

Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis

Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more

Immunology

view channel
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug...
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Microbiology

view channel
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
New Imaging Approach Could Help Predict Dangerous Gut Infection
Rapid Sequencing Could Transform Tuberculosis Care
Image: The study\'s findings show persistent standardization gaps among at-home gut microbiome testing kits (Photo courtesy of Adobe Stock)

Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits

Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more

Pathology

view channel
Novel mcPCR Technology to Transform Testing of Clinical Samples
Sex Differences in Alzheimer’s Biomarkers Linked to Faster Cognitive Decline
AI Tool Predicts Chemotherapy Response from Biopsy Slides
Image: Thermo Scientific Brilliance Candida 2 Agar and Spectra Candida Agar, color-based (chromogenic) culture media are designed to help laboratories quickly detect and differentiate clinically important Candida species (Photo courtesy of Thermo Fisher Scientific)

New Chromogenic Culture Media Enable Rapid Detection of Candida Infections

Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read more

Technology

view channel
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint...
Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms
AI-Powered Biomarker Predicts Liver Cancer Risk
Image: The AI system analyzes diverse inputs in order to make a diagnosis based on traceable reasoning (Zhao, W., Wu, C., Fan, Y. et al. Nature (2026). doi.org/10.1038/s41586-025-10097-9)

AI Model Outperforms Clinicians in Rare Disease Detection

Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more

Industry

view channel
MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition
Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical
Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss
Image: The partnership with LLS expands access to Lucent’s non-invasive blood-based biomarker tests for early detection of cognitive diseases (photo courtesy of Adobe Stock)

New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE